Literature DB >> 22111396

Multi-drug resistant tuberculosis: experiences of two tertiary referral centres.

B Kennedy1, B O'Connor, B Korn, N Gibbons, T O'Connor, J Keane.   

Abstract

Multi-drug resistant tuberculosis (MDR-TB) is associated with increased morbidity and mortality compared to drug-sensitive disease. Although MDR-TB is infrequent in Ireland, cases continue to be diagnosed in both Irish and foreign-born people. We conducted a clinical audit of 13 MDR-TB patients treated in two tertiary referral centers, the Mercy Hospital, Cork and St James's Hospital, Dublin between 2004 and 2009. The median age was 37 years. Eight patients (61.5%) were foreign-born, five (38.5%) were Irish-born. Seven patients (54%) have now stopped treatment; 6 (86%) were treated successfully and one (14%) defaulted. Mycobacterium tuberculosis isolates were resistant to a median of seven drugs. Eight patients (61.5%) developed ototoxicity from long-term aminoglycoside use. Our patients' treatment outcomes compare favourably with international reports despite a high degree of drug resistance. However, the high incidence of otoxicity is concerning.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22111396

Source DB:  PubMed          Journal:  Ir Med J        ISSN: 0332-3102


  3 in total

1.  The Impact of Concurrent Antiretroviral Therapy and MDR-TB Treatment on Adverse Events.

Authors:  Jonathan P Smith; Neel R Gandhi; N Sarita Shah; Koleka Mlisana; Pravi Moodley; Brent A Johnson; Salim Allana; Angela Campbell; Kristin N Nelson; Iqbal Master; James C M Brust
Journal:  J Acquir Immune Defic Syndr       Date:  2020-01-01       Impact factor: 3.771

2.  Novel 4-substituted phenyl-2,2'-bichalcophenes and aza-analogs as antibacterial agents: a structural activity relationship.

Authors:  Warda A Hussin; Mohamed A Ismail; Wael M El-Sayed
Journal:  Drug Des Devel Ther       Date:  2013-03-22       Impact factor: 4.162

3.  Synthesis, antimicrobial, and antiproliferative activities of substituted phenylfuranylnicotinamidines.

Authors:  Magdy M Youssef; Reem K Arafa; Mohamed A Ismail
Journal:  Drug Des Devel Ther       Date:  2016-03-11       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.